Medicine and Health Sciences Commons^™

Intravenous Thrombolytic Therapy In Acute Ischemic Stroke: Study Of Barriers And Outcome Of An Egyptian Experience, Aktham I. Alemam, Ibrahim E. Alahmar, Khaled H. Afifi, Marwa H A. Khallaf

Menoufia Medical Journal

Objectives To identify barriers against thrombolytic therapy of acute ischemic stroke (AIS) and to evaluate its efficacy and complications in Egypt. Background Tissue plasminogen activator is the only FDA-approved thrombolytic therapy for AIS. However, its use in Egypt is below best practice benchmarks. Patients and methods In a cohort observational study, 120 patients with AIS were recruited from the stroke unit of Menoufia University Hospitals and were divided into three groups: group A included 40 patients who received intravenous thrombolysis (IVT), group B included 40 patients who were eligible but did not receive IVT, and group C included 40 patients …